For many women, the decision to start or expand a family occurs during their late thirties or forties. While maternal age remains the strongest predictor of fertility, reproductive aging is far more complex than simply having fewer eggs. Fertility reflects the interaction between the brain, ovaries, endocrine system, metabolism, and overall health. Understanding these physiologic changes allows women to make informed decisions while identifying factors that may still be optimized through lifestyle, functional medicine, and evidence-based fertility care. 

The Hormonal Story Behind Female Fertility

Female fertility depends on the coordinated communication of the hypothalamic-pituitary-ovarian (HPO) axis. Throughout each menstrual cycle, the hypothalamus releases gonadotropin-releasing hormone (GnRH), stimulating the pituitary gland to produce follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones regulate follicular development, ovulation, and the production of estradiol and progesterone. 

Early in the menstrual cycle, FSH recruits a group of ovarian follicles to begin maturing. As one follicle becomes dominant, estradiol production rises, preparing the uterine lining while simultaneously signaling the pituitary to reduce FSH production. Mid-cycle, a surge in LH triggers ovulation. Following ovulation, the corpus luteum produces progesterone, preparing the endometrium for implantation and supporting early pregnancy. 

As women age, this system begins responding to a progressively shrinking pool of healthy follicles. Anti-Müllerian hormone (AMH), produced by small developing follicles, declines steadily with age as ovarian reserve decreases. Likewise, inhibin B production falls, reducing negative feedback to the pituitary and resulting in gradually increasing FSH concentrations. These hormonal changes do not directly cause infertility but instead reflect the ovaries working harder to recruit fewer remaining follicles.^10-12

The reproductive system also does not function in isolation. Thyroid hormones, adrenal function, insulin sensitivity, inflammation, and nutritional status all influence ovulation and hormone production. This interconnected physiology is one reason functional medicine evaluates fertility through the lens of whole-body health rather than focusing solely on the ovaries. 

Egg Quality: The Primary Driver of Age-Related Fertility Decline 

Although ovarian reserve often receives the most attention, egg quality is another primary factor limiting fertility after age forty. Women are born with their lifetime supply of oocytes, each remaining suspended in meiosis until ovulation. As these cells age, they accumulate mitochondrial dysfunction, oxidative stress, and DNA damage that impair their ability to divide normally during fertilization.^4-6

Mitochondria provide the energy required for accurate chromosome separation during meiosis. Over time, declining mitochondrial function leads to increased reactive oxygen species (ROS), reduced ATP production, and diminished cellular repair mechanisms. Together, these changes increase the likelihood of chromosomal abnormalities within the developing egg. 

The downstream consequence is aneuploidy. Large studies evaluating embryos undergoing preimplantation genetic testing demonstrate that chromosomal abnormalities increase dramatically after age thirty-five and exceed 90% by age forty-four.^7-9 These abnormalities account for the majority of miscarriages occurring after age forty and remain the greatest biologic barrier to achieving a healthy pregnancy.³

Knowing Your Numbers 

One of the most empowering steps women can take is understanding their hormonal baseline before fertility becomes an urgent concern. Hormone testing cannot predict whether pregnancy will occur naturally, nor can it directly measure egg quality, but it provides valuable information regarding ovarian reserve, ovulation, and endocrine health. 

AMH remains one of the most useful markers of ovarian reserve because it reflects the number of recruitable follicles remaining within the ovaries. However, AMH should not be interpreted as a measure of egg quality or a definitive predictor of natural conception.¹⁰

FSH and estradiol are typically measured early in the menstrual cycle to evaluate ovarian responsiveness. Elevated FSH levels may suggest diminished ovarian reserve, while estradiol helps place FSH values into clinical context. Mid-luteal progesterone confirms ovulation and provides insight into luteal phase function, while LH may be helpful when evaluating ovulatory disorders. 

Beyond reproductive hormones, a comprehensive fertility evaluation frequently includes thyroid function, prolactin, vitamin D status, and metabolic markers such as fasting glucose or insulin when clinically indicated. Thyroid dysfunction, insulin resistance, and hyperprolactinemia can all impair fertility independently of age and represent potentially reversible contributors to infertility.¹⁰ 

For many functional medicine practitioners, hormone testing extends beyond identifying abnormal laboratory values. The goal is to understand how hormone production, metabolism, stress physiology, nutrition, and inflammation interact to influence reproductive health and identify opportunities for individualized intervention. 

A Functional Medicine Perspective 

While no intervention can reverse ovarian aging, many aspects of reproductive health remain modifiable. Oxidative stress, chronic inflammation, metabolic dysfunction, poor sleep, nutritional deficiencies, environmental toxin exposure, and chronic psychological stress have all been associated with impaired reproductive function. 

From a functional medicine perspective, fertility reflects overall physiologic resilience. Optimizing nutrient status, supporting healthy body composition, improving insulin sensitivity, addressing sleep quality, encouraging regular physical activity, and reducing inflammatory burden may improve the environment in which oocytes mature while supporting hormonal balance throughout the reproductive years. 

These interventions should not be viewed as alternatives to reproductive medicine but rather as complementary strategies that support overall health and may optimize outcomes before and during fertility treatment. 

Treatment Options After Forty 

Although assisted reproductive technology cannot reverse age-related declines in egg quality, it remains the most effective treatment for many women experiencing age-related infertility. IVF substantially improvesthe probability of conception compared with less aggressive therapies, particularly in women over thirty-eight. However, success rates decline progressively with age because embryo aneuploidy becomes increasingly common.¹⁰

For women planning delayed childbearing, elective oocyte cryopreservation before age thirty-eight offers significantly higher future live birth rates than freezing eggs after forty. Women who require treatment later in life should receive individualized counseling regarding expected success rates, the potential role of donor oocytes, and realistic expectations based on age and ovarian reserve. 

Conclusion 

Fertility after forty reflects the intersection of reproductive aging and overall health. While maternal age remains the strongest predictor of reproductive success, understanding hormonal physiology, measuring key reproductive markers, and addressing modifiable contributors to endocrine health allows women to make informed decisions throughout their fertility journey. 

Functional medicine cannot stop ovarian aging, but it offers a framework for identifying reversible physiologic imbalances, supporting whole-body health, and complementing evidence-based fertility care. When combined with timely reproductive counseling, this comprehensive approach provides women with the greatest opportunity to optimize both fertility and long-term wellness. 

References 

1. Penzias A, et al. Optimizing natural fertility: a committee opinion. American Society for Reproductive Medicine. 2022. 
2. Wesselink AK, et al. Age and fecundability in a North American preconception cohort study. Am J Obstet Gynecol. 2017;217(6):667.e1-667.e8. 
3. Practice Committee of the American Society for Reproductive Medicine. Aging and infertility in women. Fertil Steril. 2006;86(5 Suppl 1):S248-S252. 
4. Ferreira AF, et al. Aging and oocyte competence: a molecular cell perspective. WIREs Mech Dis. 2023;15(1):e1583. 
5. Buratini J, et al. The putative roles of FSH and AMH in the regulation of oocyte developmental competence. Hum Reprod Update. 2022;28(2):232-254. 
6. Sasaki H, et al. Impact of oxidative stress on age-associated decline in oocyte developmental competence. Front Endocrinol. 2019;10:811. 
7. Franasiak JM, et al. The nature of aneuploidy with increasing age of the female partner. Fertil Steril. 2014;101(3):656-663. 
8. Matorras R, et al. Influence of parental age on chromosomal abnormalities in PGT-A embryos. J Assist Reprod Genet. 2025;42(6). 
9. Verdyck P, et al. Aneuploidy in oocytes from women of advanced maternal age. Hum Reprod. 2023;38(12):2416-2427. 
10. Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA. 2021;326(1):65-76. 
11. van den Beld AW, et al. The physiology of endocrine systems with ageing. Lancet Diabetes Endocrinol. 2018;6(8):647-658. 
12. Gouvea TM, et al. Correlation of serum anti-Mullerian hormone with hormonal and environmental parameters. Sci Rep. 2022;12:12003.